Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Operating Leases: 2019-2024

Historic Operating Leases for OptimizeRx (OPRX) over the last 6 years, with FY2024 value amounting to $209000.0.

  • OptimizeRx's Operating Leases rose 1601.83% to $507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $507000.0, marking a year-over-year increase of 1601.83%. This contributed to the annual value of $209000.0 for FY2024, which is 4366.58% down from last year.
  • As of FY2024, OptimizeRx's Operating Leases stood at $209000.0, which was down 4366.58% from $371000.0 recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Operating Leases peaked at $371000.0 during FY2023, and registered a low of $144532.0 during FY2022.
  • Over the past 5 years, OptimizeRx's median Operating Leases value was $236726.0 (recorded in 2021), while the average stood at $257358.2.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 15669.06% in 2023, then tumbled by 4366.58% in 2024.
  • Over the past 5 years, OptimizeRx's Operating Leases (Annual) stood at $325533.0 in 2020, then fell by 27.28% to $236726.0 in 2021, then crashed by 38.95% to $144532.0 in 2022, then surged by 156.69% to $371000.0 in 2023, then crashed by 43.67% to $209000.0 in 2024.
  • Its last three reported values are $209000.0 in FY2024, $371000.0 for FY2023, and $144532.0 during FY2022.